SARS -CoV-2 T-cell immunity to variants of concern following vaccination

por Gallagher, Kathleen M.E., Leick, Mark B., Larson, Rebecca C., Berger, Trisha R., Katsis, Katelin, Yam, Jennifer Y., Brini, Gabrielle, Grauwet, Korneel, Maus, Marcela V.
Publicado 2021

Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients

por How, Joan, Gallagher, Kathleen M. E., Liu, Yiwen, Katsis, Katelin, Elder, Eva L., Larson, Rebecca C., Leick, Mark B., Neuberg, Donna, Maus, Marcela V., Hobbs, Gabriela S.
Publicado 2022

Systematic Interrogation of Tumor Cell Resistance to Chimeric Antigen Receptor T-cell Therapy in Pancreatic Cancer

por Hagel, Kimberly R., Arafeh, Rand, Gang, Sydney, Arnoff, Taylor E., Larson, Rebecca C., Doench, John G., Mathewson, Nathan D., Wucherpfennig, Kai W., Maus, Marcela V., Hahn, William C.
Publicado 2023

CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity

por Joung, Julia, Kirchgatterer, Paul C., Singh, Ankita, Cho, Jang H., Nety, Suchita P., Larson, Rebecca C., Macrae, Rhiannon K., Deasy, Rebecca, Tseng, Yuen-Yi, Maus, Marcela V., Zhang, Feng
Publicado 2022

Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma

por Larson, Rebecca C., Kann, Michael C., Graham, Charlotte, Mount, Christopher W., Castano, Ana P., Lee, Won-Ho, Bouffard, Amanda A., Takei, Hana N., Almazan, Antonio J., Scarfó, Irene, Berger, Trisha R., Schmidts, Andrea, Frigault, Matthew J., Gallagher, Kathleen M. E., Maus, Marcela V.
Publicado 2023

CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma

por Choi, Bryan D., Yu, Xiaoling, Castano, Ana P., Darr, Henia, Henderson, Daniel B., Bouffard, Amanda A., Larson, Rebecca C., Scarfò, Irene, Bailey, Stefanie R., Gerhard, Genevieve M., Frigault, Matthew J., Leick, Mark B., Schmidts, Andrea, Sagert, Jason G., Curry, William T., Carter, Bob S., Maus, Marcela V.
Publicado 2019

Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources

por Schmidts, Andrea, Marsh, Leah C, Srivastava, Ambike A, Bouffard, Amanda A, Boroughs, Angela C, Scarfò, Irene, Larson, Rebecca C, Bedoya, Felipe, Choi, Bryan D, Frigault, Matthew J, Bailey, Stefanie R, Leick, Mark B, Vatsa, Sonika, Kann, Michael C, Prew, Michelle S, Kleinstiver, Benjamin P, Joung, J Keith, Maus, Marcela V
Publicado 2020

Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma

por Schmidts, Andrea, Srivastava, Ambike A, Ramapriyan, Rishab, Bailey, Stefanie R, Bouffard, Amanda A, Cahill, Daniel P, Carter, Bob S, Curry, William T, Dunn, Gavin P, Frigault, Matthew J, Gerstner, Elizabeth R, Ghannam, Jack Y, Kann, Michael C, Larson, Rebecca C, Leick, Mark B, Nahed, Brian V, Richardson, Leland G, Scarfò, Irene, Sun, Jing, Wakimoto, Hiroaki, Maus, Marcela V, Choi, Bryan D
Publicado 2022